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ABSTRACT
Behavioral addictions are considered as the 
repetitive occurrence of impulsive behaviors 
without consideration of their potential nega-
tive consequences. These addictions represent 
an increasing cost to society and are an impor-
tant new field of research in psychiatric genet-
ics. There has been a growing body of evidence 
on the familial aggregation and genetic influ-
ences on the development of behavioral addic-
tions and mainly on pathological gambling. The 
aim of this article is to critically review findings 
of family and molecular genetic studies on 
behavioral addictions, focusing on pathologi-
cal gambling and commenting on other disor-
ders where appropriate. This review provides a 
comprehensive approach to genetic studies on 
behavioral addiction and points out the neces-
sity of expanding the genetic research in this 
field. Future directions for genetic studies in 
this field are also discussed.
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INTRODUCTION
The field of behavioral addictions emerged 
in the psychiatric literature during the 1980s 
and 1990s, raising questions as to whether or 
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not a behavior could be considered addictive.1-4 
The hypothesis that certain dysfunctional but 
purposeful behaviors could produce changes 
in the brain’s reward system in the same extent 
as addictive substances have led to neurobiol-
ogy and genetics studies on behavioral addic-
tions. Despite the fact that there are still ongoing 
debates on the characterization and diagnosis 
of some behavioral addictions,5-8 researchers9-11 
have found significant evidence that supports 
the construct of behavioral addictions both in 
clinical and biological grounds. 
Behavioral addictions are considered a 
“repetitive occurrence of impulsive behaviors,”12 
without consideration of their potential nega-
tive consequences. Other characteristics of this 
group of disorders as listed by Marks1 are the 
urge to engage in a counterproductive behav-
ioral sequence, the feeling of mounting tension 
before the behavior is executed, which tempo-
rarily is relived after its completion, the return 
of the urge after a period of time (hours, days 
or weeks), the presence of external cues that 
are unique to a given behavioral addiction with 
secondary conditioning by external and inter-
nal cues, such as dysphoria, and the presence 
of an hedonic tone in early stages of the addic-
tion.  These characteristics resemble the pattern 
of substance addictions and Marks1 has stated 
that the urge in behavioral addictions could be 
understood as the craving described for sub-
stance addictions.
Behavioral addictions are frequently comor-
bid with substance abuse or dependence, 
depression, suicide attempts, and anxiety, ren-
dering significant personal, family, and finan-
cial distress. Moreover, it has been reported that 
children of pathological gamblers experience 
disruption of psychological development, which 
further increases disease severity.13,14
As in most psychiatric disorders, behavioral 
addictions seem to be the result of a complex 
interaction between biological and environmen-
tal factors. While genetic studies on behavioral 
addictions are scarce, several interesting results 
have been reported, especially regarding patho-
logical gambling. The list of syndromes under 
behavioral addictions may include pathological 
gambling, compulsive shopping, compulsive 
sexual behavior, pyromania, trichotillomania, 
and Internet addiction. This review will focus pri-
marily on pathological gambling and comment 
on the other disorders where appropriate.
The studies that are cited in this review 
were obtained through searching PubMed and 
PsychInfo databases using the keywords: “behav-
ioral addiction,” “gambling and family,” “gam-
bling and genetics,” “compulsive computer use,” 
“Internet,” “Internet addiction,” “compulsive 
sexual behavior,” “excessive sexual behavior,” 
“compulsive shopping,” “compulsive buying,” 
and “oniomania.” Studies investigating genetic 
aspects of  behavioral addictions were selected 
and included in this review.
FAMILY AND TWIN STUDIES IN 
BEHAVIORAL ADDICTIONS
Family studies are one of the most common 
strategies to investigate the inheritance of com-
plex traits or disorders, through the assessment 
of blood relatives of an affected individual (pro-
band). The information is obtained either by ask-
ing the proband about their family members 
(family-history method) or through direct inter-
view of the relatives (family-study method). This 
study design provides information on the famil-
ial segregation of the disorder, which can be the 
result of not only genetic, but also environmen-
tal factors. In order to determine whether a non-
Mendelian disorder or trait runs in families, it 
is necessary to quantify the risk of a proband’s 
relatives to be affected by the disease compared 
with the population risk of the disease. This mea-
sure can be calculated for all relatives and values 
will be closer to one in distant relatives.15 
Another approach to family studies is to com-
pare the frequency of the disorder or trait under 
investigation and comorbid disorders in relatives 
of the proband and compare the obtained data 
to relatives of control subjects. These studies are 
usually conducted on first-degree relatives of 
the proband and comprise the majority of family 
studies conducted on pathological gambling.
Twin studies can help elucidate the extent 
to which genetic factors are responsible for the 
development of a certain trait or disorder (pheno-
type). Monozygotic (MZ) or identical twins share 
100% of their genes because they are derived 
from the same zygote. Dizygotic (DZ) or frater-
nal twins share, on average, 50% of their genes 
as do any siblings. Thus, when genetic factors 
account for most of the variance of a phenotype, 
MZ twins will present a significantly higher con-
cordance rate compared to DZ twins. This study 
design assumes that twins raised in the same 
setting are exposed for the most part to the same 
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environment (shared family environment). Both 
MZ and DZ twins are raised during the same 
time period, thus sharing experiences that are 
related to a specific time frame in the family’s 
history, which might not be possible for non-
twins. However, environmental exposure can be 
different even in twins raised together, for exam-
ple for experiences with different friends and the 
type of relationship each twin develops with the 
parents. This type of environmental exposure is 
usually referred to as nonshared or unique envi-
ronmental experiences. Currently, a number of 
genetic modelling techniques are available that 
allow for testing of environmental effects in twin 
studies. It is not the purpose of this review to 
discuss these statistical procedures, but a thor-
ough description of genetic modelling is avail-
able from Neale and colleagues.16
Family Studies in Pathological Gambling
Initial evidence towards family aggregation 
of pathological gambling came from the find-
ing that the risk of pathological gambling was 
associated with parental gambling,17-20 and that 
children of pathological gamblers were more 
vulnerable to develop dysfunctional behav-
iors.14,17 Gambino and colleagues21 investigated 
the frequency of perceived addictive problems 
for parents and grandparents in a sample of 
93 United States Veterans Affairs population of 
drug and alcohol abusers. Gambling behavior 
was assessed through the South Oaks Gambling 
Screen in which scores of 3 or 4 indicate a poten-
tial pathological gambler or a problem gambler 
and scores >5 indicate a potential pathological 
gambler.22 Through the South Oaks Gambling 
Screen scores 17.3% (n=16) of the subjects were 
considered as probable pathological gamblers 
and 14% (n=13) as potential pathological gam-
blers. Subjects who reported gambling problems 
among their parents had a three times higher 
liability of scoring as a probable pathological 
gambler. Interestingly, those who perceived 
their grandparents as problem gamblers were 
at 12 times the risk of being a problem gambler 
compared to those who did not report gambling 
problems among their grandparents. 
Some studies have investigated the exposure 
to gambling in families. Gupta and Derevensky23 
assessed a sample of 477 children 9–14 years of 
age who reported gambling on a regular basis, 
of whom 86% reported gambling with their rela-
tives. Although there is no evaluation regarding 
problem or pathological gambling among these 
youths, this finding points to the importance of 
family environment in the development of a gam-
bling habit. In a subsequent study,24 these authors 
evaluated 817 high-school students among which 
4.7% were diagnosed as pathological gamblers. 
The adolescents who were diagnosed with patho-
logical gambling were also more likely to report 
having parents with a gambling problem, a find-
ing that has been reported in other samples of 
adolescents and young adults.20,25,26 Other stud-
ies evaluating adults with substance abuse or 
dependence,18,19,27,28 pathological gamblers,29,30 and 
prisoners31 also reported an association of patho-
logical gambling with parental gambling. These 
results add the familial factor to previous findings 
that have reported an association of adult prob-
lem gambling with exposure to gambling during 
childhood.32 The results of a recent investigation 
on a community sample of 938 adolescents (496 
females, 442 males) and their parents showed 
that the occurrence of gambling problems in ado-
lescents was related only to the father’s severity 
of problem gambling.33 
Pathological gamblers also reported higher 
rates of pathological gambling among their first-
degree relatives. The assessment of 14 pathologi-
cal gamblers through the Family History Research 
Diagnostic Criteria showed that at least 9% of their 
relatives had a gambling disorder.34 The compari-
son group was not assessed for gambling behav-
ior, but the results also show a higher frequency 
of pathological gambling in first degree relatives 
of pathological gamblers compared to the popu-
lation prevalence.35 In a larger sample of 31 path-
ological gamblers and 193 first-degree relatives, 
using both the family-history and the family-inter-
view method, Black and colleagues36 reported a 
frequency of 8.3% for pathological gambling and 
12.4% for any gambling disorder among first-
degree relatives of pathological gamblers which 
was significantly higher when compared with 
first-degree relatives of a control group (2.1% for 
pathological gambling and 3.5% for any gambling 
disorder). This is, to our knowledge, the only fam-
ily study in pathological gambling with a similar 
male-to-female ratio sample (16 men, 15 women) 
and a gender-matched control group. Although 
the sample sizes in these family studies are rela-
tively small, the consistency of the reports pro-
vides fairly solid support for the importance of 
heritable factors in pathological gambling.
Review Article
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Family Studies in Compulsive Buying
The first family history investigation on com-
pulsive buying was conducted on 18 subjects, of 
which three (16.7%) reported to have one relative 
with compulsive buying.37 Black and colleagues38 
investigated psychiatric disorders in 33 compul-
sive buyers, finding that 13 (9.5%) of first-degree 
relatives had the same symptomatology. The 
absence of comparison with a control group and 
the small sample sizes constitute important limita-
tions of these studies. Nevertheless, it is notewor-
thy that in both studies the reported frequencies 
of compulsive buying among relatives are higher 
than the reported prevalence of 1.1% in a general 
population sample.39
Twin Studies 
 The largest twin investigation in pathologi-
cal gambling derives form the analysis of 3,359 
male twin pairs of the Vietnam Era Twin Registry. 
Eisen and colleagues40 found that inherited fac-
tors explained between 35% and 54% of the 
liability for developing any symptom of patho-
logical gambling. For example, they reported 
that the presence of the symptom “gambling 
larger amounts than intended” was composed 
by 55% of genetic factors and 45% of environ-
mental factors, thus, both genetic and environ-
mental factors contributed to this symptom with 
genetic factors accounting for 55% of the vari-
ance. Also, inherited factors explained 54% of 
the liability for the report of two or more symp-
toms of pathological gambling. The lifetime rates 
of pathological gambling among MZ and DZ co-
twins of pathological gamblers were 22.6% and 
9.8%, respectively and heritability estimate for 
the diagnosis of pathological gambling was 46%.
Family studies can provide important informa-
tion regarding questions about continuity of a 
diagnosis by examining the risk of a particular dis-
order among the relatives of individuals diagnosed 
with either the disorder itself or with sub-clinical 
forms of the same condition. Thus, this sample 
was subsequently analyzed in order to investigate 
the causes of the high comorbidity between patho-
logical gambling and alcohol dependence, and the 
hypothesis of a continuity model for pathological 
gambling.41 Results showed that the risk of patho-
logical gambling was significantly higher among 
DZ and MZ co-twins of subjects with subclinical 
pathological gambling (one to three Diagnostic 
and Statistical Manual of Mental Disorders, Third 
Edition-Revised pathological gambling symptoms) 
compared with co-twins of men with no pathologi-
cal gambling symptoms. 
These results were consistent with the hypothe-
sis that the differences between problem and path-
ological gambling are solely quantitative, meaning 
that these disorders represent a continuum of the 
same phenotype, therefore likely sharing the same 
risk factors. Men with subclinical pathological gam-
bling were at a significantly higher risk for alcohol 
dependence when compared with men without 
pathological gambling symptoms. Also, the risk of 
alcohol dependence was higher in DZ and MZ co-
twins of subjects with subclinical pathological gam-
bling compared with those with no pathological 
gambling symptoms. The authors suggested that 
there is at least one genetic locus that increases 
the susceptibility for both pathological gambling 
and alcohol dependence. 
The relationship between gambling and other 
psychiatric disorders were also investigated 
in this large sample. Slutske and colleagues42 
investigated the association of pathological gam-
bling with antisocial behavior disorders (anti-
social personality disorder, conduct disorder, 
and adult antisocial behavior) and the results 
suggest that the comorbidity of antisocial dis-
orders with pathological gambling is in part a 
consequence to their sharing a common genetic 
vulnerability. The results of an investigation on 
environmental and genetic contributions to the 
comorbidity of pathological gambling and major 
depressive disorder in the Vietnam Era Twin reg-
istry sample suggest that overlapping genetic 
factors are strong determinants of the correla-
tion between these disorders.43 These findings 
support the results of previous studies in smaller 
samples regarding a higher comorbidity rate of 
alcohol dependence, substance addiction, and 
mood disorders among first-degree relatives of 
pathological gamblers.34,36,44 
Another twin study was conducted in a sample 
of 92 male and 63 female MZ and DZ twins who 
were assessed for overall gambling behavior dur-
ing the year prior to the study.45 The authors found 
that genetic factors were significantly respon-
sible for “high action” gambling, such as slot 
machines and roulette, in male twins. No signifi-
cant genetic influence was found among males 
for “low action” games (eg, betting on sports 
events or on games of skill), and no significant 
genetic influence among the female MZ and DZ 
twin pairs for both types of games. The results 
should be viewed cautiously, however, due to the 
CNS Spectr 11:12 © MBL Communications Inc. December 2006
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small sample size of the twins, and the somewhat 
limited assessment of the gambling behavior. 
The authors do not report the rate of problem 
or pathological gambling and do not assess any 
pathological gambling symptoms in the sample. 
Thus far, according to the PubMed and 
PsychInfo search of the literature, there are no 
other published family or twin studies available 
on compulsive buying, compulsive sexual behav-
ior, or compulsive computer use.
Molecular Genetic Studies
Genetic association studies are one of the 
most useful study designs in the investigation of 
complex phenotypes because, when done with 
proper controls, they have good statistical power 
to detect moderate to small genetic effects. The 
choice of genes to test for association is usually 
made according to findings on the neurobiology 
of the disorder, and these are referred to as can-
didate gene studies. The analysis will investigate 
if there is a significant difference in the frequency 
of a given genetic variant (allele, polymorphism) 
between case and control groups. One of the 
main caveats of candidate gene association stud-
ies is the potential for false-positive results due to 
type I error.46 This type of error is the result of an 
increased number of independent variables, mul-
tiple testing or population stratification. Even so, 
well conducted genetic association studies rep-
resent one of the most valid approaches for psy-
chiatric genetics investigations.46,47 Another type 
of molecular genetic investigation is called link-
age analysis. To date, there are no linkage studies 
available on behavioral addictions.
Research on the molecular genetics of behav-
ioral addictions has been conducted mostly in 
pathological gambling, taking into consideration 
the diverse clinical and behavioral characteris-
tics of this disorder, and one study has been con-
ducted on compulsive buying. These studies are 
summarized in the Table.
The involvement of the brain’s reward system 
in addictive behaviors has led to investigations 
on dopamine system genes. Initial genetic studies 
reported associations of pathological gambling 
with alelle1 of the dopamine (D)2 receptor gene 
(DRD2) TaqIA polymorphism.48,49 These associa-
tions are more complicated to interpret given the 
recent findings that the D2 TaqIA marker is known 
to be outside the DRD2 gene, located in a neighbor 
gene to DRD2 called the ankyrin repeat and kinase 
domain containing-1 gene (ANKK1).50 Thus, it is 
currently not possible to determine if this marker 
is associated with dopamine receptor function, 
since the relation of ANKK1 gene function to DRD2 
is unknown to date. An association of comorbid 
pathological gambling and alcohol dependence 
with the homozygous genotypes of the D1 recep-
tor gene (DRD1 DdeI) has been reported.49 Both 
polymorphisms appear to alter the function of 
these genes.50-53 D1 and D2 receptors have opposite 
effects, stimulating and inhibiting, respectively, the 
enzyme adenylyl cyclase. The interaction between 
D1 and D2 receptors54 has been associated with 
craving and drug-seeking behavior.55
A polymorphism in exon III of the dopamine 
D4 receptor gene (DRD4) exon III variable-num-
ber-of-tandem-repeats (VNTR) has been reported 
to encode a receptor with lower affinity for dopa-
mine,56-58 and to be associated with impulsive 
personality traits.59-61 The association of the DRD4 
exon III VNTR with pathological gambling was 
investigated in two studies,62,63 and associations 
with the 7 repeat allele and with the overall long 
forms of the polymorphism (5–8 repeats)63 were 
reported. It should be noted that in one study,62 
this polymorphism was reported to be associ-
ated only with the vulnerability to pathological 
gambling in females.
Deficient impulse control and impulsive per-
sonality features also have suggested the involve-
ment of serotonergic and noradrenergic pathways 
in pathological gambling.64-67 A variant in the pro-
moter region of the serotonin transporter gene 
(5HTTLPR) was found to be significantly associ-
ated with pathological gambling in males.68 The 
long variant of this polymorphism is associated 
with increased promoter activity and thus higher 
production of the serotonin transporter protein. 
The genetic association with 5HTTLPR was not 
found in females.68 Subsequent investigations in 
this same sample revealed an association of the 
more severe forms of pathological gambling in 
males with a 3 repeat allele in the promoter region 
of the monoamine oxidase A (MAO-A) gene 30 
base pairs VNTR and with a polymorphism in the 
first intron of the same gene, further suggesting 
a sex-related effect in the genetics of pathological 
gambling.69,70 The MAO-A gene is located on the 
X chromosome, thus, there is a greater likelihood 
that sex differences in its expression may occur.
Comings and colleagues71 analyzed the effect 
of 31 genes involved in dopamine, serotonin, 
norepinephrine, and γ-aminobutyric acid path-
ways in 139 pathological gamblers and 139 con-
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68 PG (47 males,  
21 females)
68 ethnically, 
gender, and  
age matched
DRD4 (exon III) 7 repeat allele associated 
with PG in females
Comings  
et al (1997)49









68† PG 68* 5HTTLPR Short allele associated 
with PG in males
Comings  
et al (1999)63
165* PG 124 DRD4 (exon III) 5–8 repeat and 7 repeat 
alleles associated with PG
Ibañez et al 
(1999)72
68† PG 68* TH (intron 1) No association
Ibañez  
et al (2000)70
68† PG 68* MAO-A (intron 1)
MAO-A (promoter)
MAO-B (intron II)
4 repeat allele associated 
with PG in males
3 repeat allele associated 




139 PG 139 ethnically, 
gender, and  
age matched
31 genes involved in 
dopamine, 5-HT, nor-
adrenaline, and GABA  
neurotransmitters
Genes in dopaminergic, 
noradrenergic and gluta-
matergic neurotransmitter 
systems accounted for 




68† PG 68* MAO-A (promoter) 3 repeat allele associated 




21 CB 38 SLC6A4 (intron 2) 
5HTTLPR 
No association
* Derived from the same sample as in Comings et al.48
† Same sample as in Perez de Castro et al.62
PG=pathological gambling; DRD2=dopamine D2 receptor gene; DRD1 (DdeI)=nucleotide substitution in the promoter region of the gene; 5HTTLPR=promoter 
polymorphism of the serotonin transporter gene; TH=tryptophan hydroxylase gene; MAO-A=monoamine oxidase A gene; MAO-B=monoamine oxidase B gene; 
5-HT=serotonin; GABA=γ-aminobutyric acid; CB=compulsive buying; SLC6A4=serotonin transporter gene. 
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trols. The most significant associations were 
found with the D2 and D4 receptors, the dopa-
mine transporter, tryptophan hydroxylase, the 
α-2C adrenergic receptor, the glutamate receptor 
subunit 1, and the presenilin 1 genes. Dopamine, 
serotonin, and norepinephrine genes contrib-
uted approximately equally to the risk for path-
ological gambling, with each gene accounting 
for <2% of the variance. These results indicate 
that genes influencing a range of brain functions 
play an additive role as risk factors for patho-
logical gambling. Nevertheless, the investigation 
of a large number of polymorphisms and the 
fact that only male pathological gamblers were 
assessed constitute important limitations for the 
interpretation of these results. 
937
Currently, one study73 on the molecular genet-
ics of compulsive buying has been published, 
in which the authors report no association with 
two polymorphisms in the serotonin transporter 
gene. This investigation was conducted in a small 
sample that lacked power to detect association 
for small effect alleles. 
CONCLUSION
Studies on the molecular and epidemiological 
genetics of behavioral addictions are few, most 
of them on pathological gambling, with small 
samples, and mainly on male subjects. Recent 
reviews9,74 emphasize the need for further inves-
tigation in larger, well-characterized, and more 
diverse samples. 
The results from family studies, mainly from 
the Vietnam Era twin sample, further reveal the 
complexity of the pathological gambling pheno-
type. In fact, these results point to the complex 
relationship between different psychiatric condi-
tions, such as addictions, mood disorders, and 
antisocial personality disorder. It is possible to 
hypothesize that studies on genetic vulnerabil-
ity factors could help unravel not only the com-
monalities between substance and behavioral 
addictions but also the extent to which addic-
tions, depression, and personality disorders are 
intertwined. Recently, a classification of mental 
disorders as a result of internalizing or external-
izing factors was proposed, and although patho-
logical gambling was not part of the analysis, 
addictions presented a better fit in the external-
izing factor model.75 Nevertheless, evidence of 
a common genetic vulnerability for pathological 
gambling and major depression raises the ques-
tion of whether it would be appropriate to clas-
sify pathological gambling as an externalizing 
disorder due to the fact that major depression 
was considered as an internalizing disorder.43
The twin study conducted by Winters and Rich45 
suggested a genetic liability for overall gambling 
behavior in males and in high-action games. 
However, this study presents important limita-
tions: the authors only examined the frequency of 
overall gambling behavior with no further detail; 
a relatively small sample size; and a participant 
mean age of 26 years, when gambling may not 
have been manifested yet.76 
Clinical studies77-79 have reported gender dif-
ferences concerning the diagnosis, course, and 
treatment of pathological gamblers, which further 
suggest the possibility of a sex-related effect on 
the genetics of pathological gambling. In previ-
ous studies,37,38,80-83 females seemed to be the great 
majority of compulsive buyers. However, the first 
study conducted on a general population sample 
of 2,513 adults84 found similar prevalences of com-
pulsive buying for males (5.5%) and females (6%).
Age at onset of pathological gambling needs 
to be further investigated in genetic studies. 
Although the family study conducted by Black 
and colleagues36 found no effect of earlier age at 
onset on pathological gambling, epidemiological 
and family studies suggest that later onset could 
be associated with a faster progression from 
social to problem gambling and pathological 
gambling.77,85 These results suggest that it may 
be useful to investigate whether different genetic 
factors are associated with a faster progression to 
pathological gambling and later age at onset.
As noted earlier, multiple testing remains an 
issue in most molecular genetic association stud-
ies. Most correction methods available are con-
sidered to be overly strict.86 The consequence of 
using conservative methods for multiple-testing 
correction is an exponential increase in type II 
error, that is, the failure to consider an association 
when it truly exists. Considering that psychiatric 
phenotypes are expected to be associated with 
multiple polymorphisms, each with a small effect 
size, a more plausible method for multiple-testing 
correction remains as an important topic to be 
addressed. Despite limitations, the reported asso-
ciations should be given full consideration given 
the consistency of these results with pathological 
gambling biological hypotheses.
This review and neurobiology studies on 
pathological gambling and other behavioral 
addictions suggest that future studies should 
investigate genes involved in impulsivity and the 
brain’s reward system. Dopamine receptor genes 
should be further investigated, especially those 
with a higher possibility for drug development, 
such as DRD3.87 Serotonin receptor and trans-
porter genes are also associated with impulse 
control and are important candidate genes in the 
study of behavioral addictions. Other genes that 
have been associated with conditions that are 
highly comorbid with behavioral addictions are 
also important to be investigated. One of these is 
the brain derived neurotrophic factor gene, which 
has been recently associated with depression88 
and nicotine dependence,89 both conditions being 
frequently comorbid with pathological gambling. 
Of interest, brain derived neurotrophic factor and 
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DRD3 genes have been shown to interact and this 
combination may be a fruitful direction to investi-
gate in future genetic studies.
 This review also points out the necessity 
for family studies on other behavioral addic-
tions, such as compulsive buying, compulsive 
sexual behavior and compulsive computer use. 
Aside from evidence for family aggregation, 
these studies can yield important information 
regarding comorbid conditions and genetic and 
environmental effects that could help refine the 
phenotype of behavioral addictions. Compulsive 
computer use, a rapidly expanding problem, 
needs more detailed measurement, for exam-
ple, time spent on different activities, includ-
ing Internet sites for shopping, pornography, or 
gambling. Due to the lack of genetic studies on 
compulsive buying, compulsive sexual behavior 
and compulsive computer use, it is early to spec-
ulate whether genetic findings in these behav-
ioral addictions would be similar to the findings 
on pathological gambling. However, if neurobi-
ology or neuroimaging studies show that simi-
lar areas are activated in pathological gambling 
and other behavioral addictions, it would be rea-
sonable to hypothesize that molecular genetics 
findings would be consistent across different 
behavioral addictions. 
 It is also of importance to mention that a recent 
review on substance addiction and genetic vul-
nerability reports that the DRD2, DRD4, and cat-
echol-O-methyltransferase genes are the more 
consistently associated to substance abusers 
compared to controls.90 This report represents evi-
dence toward similar molecular genetics findings 
on substance addiction and pathological gam-
bling. However, further studies with larger sam-
ples are paramount to confirm this hypothesis. 
Overall, we expect in the near future that devel-
opments in the clinical assessment, biology, and 
genetics will improve the diagnosis, and possibly 
treatment and prevention strategies in the field of 
behavioral addictions. CNS
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